Cargando…

Effectiveness of BNT162b2 Vaccine Booster against SARS-CoV-2 Infection and Breakthrough Complications, Israel

We estimated vaccine effectiveness (VE) of the BNT162b2 (Pfizer-BioNTech, https://www.pfizer.com) booster dose against SARS-CoV-2 infection and reduction of complications (hospitalization, severe disease, and death) among breakthrough cases in persons in Israel >16 years of age for <20 weeks....

Descripción completa

Detalles Bibliográficos
Autores principales:	Glatman-Freedman, Aharona, Bromberg, Michal, Hershkovitz, Yael, Sefty, Hanna, Kaufman, Zalman, Dichtiar, Rita, Keinan-Boker, Lital
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Centers for Disease Control and Prevention 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9045419/ https://www.ncbi.nlm.nih.gov/pubmed/35361311 http://dx.doi.org/10.3201/eid2805.220141

Ejemplares similares

Effectiveness of BNT162b2 Vaccine in Adolescents during Outbreak of SARS-CoV-2 Delta Variant Infection, Israel, 2021
por: Glatman-Freedman, Aharona, et al.
Publicado: (2021)

Effectiveness of BNT162b2 Vaccine against Omicron Variant Infection among Children 5–11 Years of Age, Israel
por: Glatman-Freedman, Aharona, et al.
Publicado: (2023)

The BNT162b2 vaccine effectiveness against new COVID-19 cases and complications of breakthrough cases: A nation-wide retrospective longitudinal multiple cohort analysis using individualised data
por: Glatman-Freedman, Aharona, et al.
Publicado: (2021)

The impact of SARS-CoV-2 on respiratory syndromic and sentinel surveillance in Israel, 2020: a new perspective on established systems
por: Glatman-Freedman, Aharona, et al.
Publicado: (2022)

Under-diagnosis of SARS-CoV-2 infections among children aged 0–15 years, a nationwide seroprevalence study, Israel, January 2020 to March 2021
por: Indenbaum, Victoria, et al.
Publicado: (2021)

Myocarditis after BNT162b2 Vaccination in Israeli Adolescents
por: Mevorach, Dror, et al.
Publicado: (2022)

Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel
por: Mevorach, Dror, et al.
Publicado: (2021)

Predominance of a Drifted Influenza A (H3N2) Clade and Its Association with Age-Specific Influenza Vaccine Effectiveness Variations, Influenza Season 2018–2019
por: Glatman-Freedman, Aharona, et al.
Publicado: (2020)

Disordered eating among Arab and Jewish youth in Israel: the role of eating dinner with the family
por: Elran-Barak, Roni, et al.
Publicado: (2020)

Effectiveness of influenza vaccine in preventing medically-attended influenza virus infection in primary care, Israel, influenza seasons 2014/15 and 2015/16
por: Yaron-Yakoby, Hamutal, et al.
Publicado: (2018)

Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel
por: Bar-On, Yinon M., et al.
Publicado: (2021)

Delayed respiratory syncytial virus epidemic in children after relaxation of COVID-19 physical distancing measures, Ashdod, Israel, 2021
por: Weinberger Opek, Moran, et al.
Publicado: (2021)

Diversity in the Circulation of Influenza A(H3N2) Viruses in the Northern Hemisphere in the 2018–19 Season
por: Pando, Rakefet, et al.
Publicado: (2021)

Factors associated with childhood influenza vaccination in Israel: a cross-sectional evaluation
por: Glatman-Freedman, Aharona, et al.
Publicado: (2019)

Preventable Cancer in Israel
por: Magid, Avi, et al.
Publicado: (2022)

Factors associated with choice of approach for Group B streptococcus screening
por: Sefty, H., et al.
Publicado: (2016)

Trends of Thyroid Cancer in Israel: 1980–2012
por: Keinan-Boker, Lital, et al.
Publicado: (2016)

A COVID-19 call center for healthcare providers: dealing with rapidly evolving health policy guidelines
por: Glatman-Freedman, Aharona, et al.
Publicado: (2020)

Waning Immunity after the BNT162b2 Vaccine in Israel
por: Goldberg, Yair, et al.
Publicado: (2021)

A Significant Decrease in the Incidence of Shigellosis in Israel during COVID-19 Pandemic
por: Bassal, Ravit, et al.
Publicado: (2021)

The Israel National Sera Bank: Methods, Representativeness, and Challenges
por: Bassal, Ravit, et al.
Publicado: (2021)

Effects of BNT162b2 Covid-19 Vaccine Booster in Long-Term Care Facilities in Israel
por: Muhsen, Khitam, et al.
Publicado: (2021)

Immune Responses After Vaccination With Primary 2-Dose ChAdOx1 Plus a Booster of BNT162b2 or Vaccination With Primary 2-Dose BNT162b2 Plus a Booster of BNT162b2 and the Occurrence of Omicron Breakthrough Infection
por: Choi, Seong-Ho, et al.
Publicado: (2023)

Protection by a Fourth Dose of BNT162b2 against Omicron in Israel
por: Bar-On, Yinon M., et al.
Publicado: (2022)

BNT162b2 vaccine breakthrough: clinical characteristics of 152 fully vaccinated hospitalized COVID-19 patients in Israel
por: Brosh-Nissimov, Tal, et al.
Publicado: (2021)

Genetic divergence of Influenza A(H3N2) amino acid substitutions mark the beginning of the 2016–2017 winter season in Israel
por: Glatman-Freedman, Aharona, et al.
Publicado: (2017)

Non-Dairy Animal Protein Consumption Is Positively Associated with Overweight and Obesity in Israeli Adolescents
por: Dor, Chen, et al.
Publicado: (2022)

Practices and attitudes of bariatric surgeons in Israel during the first phase of the COVID-19 pandemic
por: Beglaibter, Nahum, et al.
Publicado: (2020)

Omicron BA.1 neutralizing antibody response following Delta breakthrough infection compared with booster vaccination of BNT162b2
por: Yamamoto, Shohei, et al.
Publicado: (2023)

Protection against Covid-19 by BNT162b2 Booster across Age Groups
por: Bar-On, Yinon M., et al.
Publicado: (2021)

Estimated Infection and Vaccine Induced SARS-CoV-2 Seroprevalence in Israel among Adults, January 2020–July 2021
por: Bassal, Ravit, et al.
Publicado: (2022)

Breakthrough Infections in BNT162b2-Vaccinated Health Care Workers
por: Lange, Bettina, et al.
Publicado: (2021)

Ineffectiveness of the 2014-2015 H3N2 influenza vaccine
por: Mandelboim, Michal, et al.
Publicado: (2015)

Exposure to environmental tobacco smoke in non - smoking adults in Israel: results of the second Israel biomonitoring survey
por: Berman, Tamar, et al.
Publicado: (2018)

BNT162b2 Vaccine Booster and Mortality Due to Covid-19
por: Arbel, Ronen, et al.
Publicado: (2021)

Frosted branch angiitis after booster vaccination with BNT162b2
por: Haas, A.-M., et al.
Publicado: (2023)

The effect of Omicron breakthrough infection and extended BNT162b2 booster dosing on neutralization breadth against SARS-CoV-2 variants of concern
por: Graham, Carl, et al.
Publicado: (2022)

Effect of Elevated Basal Insulin on Cancer Incidence and Mortality in Cancer Incident Patients: The Israel GOH 29-year follow-up study
por: Dankner, Rachel, et al.
Publicado: (2012)

Comparison of COVID-19 Incidence Rates Before and After School Reopening in Israel
por: Somekh, Ido, et al.
Publicado: (2021)

Immunogenicity of a BNT162b2 vaccine booster in health-care workers
por: Saiag, Esther, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_d08kk0psob17vk6v4se319fvtt